In this episode of the Diabetes Innovators Series, Rob interviews Jonathan

Rigby, CEO of Sernova Biotherapeutics, about the innovative approaches to

treating type 1 diabetes, particularly through the development of a

biohybrid organ known as the cell pouch. Jonathan shares his personal

journey as a type 1 diabetic and discusses the clinical trials, patient

selection, and the future of diabetes treatment, including the challenges

of immunosuppression and the complexities of daily diabetes management. The

conversation emphasizes the importance of innovation in diabetes care and

the hope for a future where patients can achieve insulin independence.

Chapters

00:00 Introduction to Diabetes and Innovation

02:51 The Cell Pouch Biohybrid Organ

05:53 Clinical Trials and Patient Selection

08:48 Living with Type 1 Diabetes

11:51 Future of Diabetes Treatment

14:47 Immunosuppressants and Cell Acceptance

17:48 The Complexity of Diabetes Management

20:44 Conclusion and Future Outlook

Resources:

Sernova

Jonathan Rigby LinkedIn